Cargando…
A systematic review of infliximab in the treatment of early rheumatoid arthritis
BACKGROUND: Several health authorities have recently revised the indication of infliximab (IFX) to include the treatment of early rheumatoid arthritis (RA). The aim of this systematic review of the literature was to appraise the efficacy, safety, and cost-effectiveness of early therapy with IFX. MET...
Autores principales: | Du Pan, Sophie Martin, Gabay, Cem, Finckh, Axel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376089/ https://www.ncbi.nlm.nih.gov/pubmed/18473014 |
Ejemplares similares
-
Infliximab in the treatment of rheumatoid arthritis
por: Perdriger, A
Publicado: (2009) -
Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients
por: Singwe-Ngandeu, Madeleine, et al.
Publicado: (2010) -
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists
por: Finckh, Axel, et al.
Publicado: (2012) -
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
por: Jarlborg, Matthias, et al.
Publicado: (2020) -
Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis
por: Brulhart, Laure, et al.
Publicado: (2019)